Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Hims & Hers Health ( (HIMS) ) has provided an update.
Hims & Hers Health, Inc. has expanded its board of directors, appointing Deb Autor as the tenth member. She will serve until the 2025 annual meeting and is deemed independent under NYSE standards. Autor will also provide consulting services for a year, earning a $100,000 fee. Her appointment includes joining the Risk Committee alongside other notable directors.
See more data about HIMS stock on TipRanks’ Stock Analysis page.
